Analysis of the contribution of ENDOG expression to cell proliferation in diverse tumor cell lines with different status of the PTEN/p-AKT pathway further demonstrated that ENDOG silencing targets p-AKT-dependent signaling to reduce cell proliferation. The gene discussed is AKT1; the disease is neoplasm.